Healio

Sub-Tenon injection of mitomycin C may have advantages over sponge application

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Sub-Tenon injection of mitomycin C may be ...
InfoQ

Gremlin Releases Application Level Fault Injection (ALFI) Platform for Targeted Chaos Experiments

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Senyo Simpson discusses how Rust's core ...
Computerworld

Glastopf Web application honeypot gets SQL injection emulation capability

The Honeynet Project, a non-profit organization that develops open-source security research tools, has created a component for the Glastopf Web application honeypot software that can emulate ...
The Mercury

Braeburn Resubmits New Drug Application for BRIXADITM (buprenorphine) Extended-Release Subcutaneous Injection for Moderate to Severe Opioid Use Disorder

PLYMOUTH MEETING, Pa., June 15, 2021 /PRNewswire/ — Braeburn announces that today the New Drug Application (NDA) for BRIXADI (buprenorphine) extended-release injection for subcutaneous (SC) use (CIII) ...
Yahoo Finance

The New Drug Application for KN026 (Anbenitamab Injection) Has Been Accepted by the National Medical Products Administration

SUZHOU, China, Sept. 12, 2025 /PRNewswire/ -- Alphamab Oncology (Stock Code: 9966.HK) announced that the New Drug Application (NDA) for anbenitamab injection (KN026), independently developed by the ...
InfoQ

Using Code Instrumentation for Fault Injection at the Application Level at eBay

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Kenneth Harris, a NASA veteran who worked on ...
Business Wire

Revance Resubmits Biologics License Application for DaxibotulinumtoxinA for Injection for Glabellar Lines to the FDA

NASHVILLE, Tenn.--(BUSINESS WIRE)--Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, today announced it has resubmitted its ...
KTLA

FDA Accepts Braeburn's New Drug Application Resubmission for BRIXADI™ (buprenorphine) Extended-Release Subcutaneous Injection for Moderate to Severe Opioid Use Disorder

PLYMOUTH MEETING, Pa., Dec. 8, 2022 /PRNewswire/ -- Braeburn announces that the New Drug Application (NDA) for BRIXADI (buprenorphine) extended-release weekly and monthly injections for subcutaneous ...